Table 1 Demographic, clinical, sleep, and biological data of central hypersomnia patients and healthy controls in miRNA screen study
Narcolepsy (N = 20) | Healthy controls (N = 20) | |
|---|---|---|
Gender (male), n (%) | 8 (40 %) | 10 (50 %) |
Age, years | 28.43 (± 6.25) | 30.25 (± 5.89) |
Body mass index (BMI) | 25.70 (± 2.28) | 21.20 (± 1.92) |
Age of onset, years | 19.76 (± 2.95) | – |
Disease duration | 12.30 (± 4.90) | – |
Epworth sleepiness scale | 19.00 (± 2.09) | – |
Cataplexy, n (%) | 18 (90 %) | – |
Hypnagogic hallucinations, n (%) | 18 (90 %) | – |
Sleep paralysis, n (%) | 20 (100 %) | – |
Awakenings/night | 5.93 (± 3.21) | – |
Sleep latency, sec | 296.08 (± 102.25) | – |
PSGa—Total sleep time (TST), min | 398.90 (± 80.21) | – |
PSGa—Sleep efficiency, % | 87.32 % (± 60.28) | – |